LONG MINI FUTURE WARRANT - AMGEN | Real-time BOERSE MUENCHEN 12:25:10 2024-07-16 pm EDT | ||
| 8.62 EUR | +3.86% |
|
| Current month | +18.57% | ||
| 1 month | +46.13% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 8.62 | +3.86% |
| 24-07-15 | 8.3 | -4.16% |
| 24-07-12 | 8.66 | +6.91% |
| 24-07-11 | 8.1 | +6.72% |
| 24-07-10 | 7.59 | +9.68% |
Real-time BOERSE MUENCHEN
Last update July 16, 2024 at 12:25 pm EDT
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP94AG |
| ISIN | DE000GP94AG0 |
| Date issued | 2023-07-18 |
| Strike | 238.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.49 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.84 € |
|---|---|
| Lowest since issue | 0.719 € |
| Spread | 0.02 € |
| Spread % | 0.23% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
